Secondary prevention of coronary heart disease in primary care: a healthy heart initiative

被引:13
作者
Flanagan, DEH
Cox, P
Paine, D
Davies, J
Armitage, M
机构
[1] Royal Bournemouth Hosp, Dept Audit & Clin Effect, Bournemouth BH7 7DW, Dorset, England
[2] Bournemouth Diabet & Endocrine Ctr, Bournemouth, Dorset, England
关键词
D O I
10.1093/qjmed/92.5.245
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
We assessed the effectiveness of secondary prevention of coronary heart disease (CHD) in primary care, in a cross-sectional study of 1015 patients aged <75 years with documented CHD. Patients records were examined for documentation of CHD risk factors; 722 patients then attended education sessions where blood pressure and cholesterol were measured, a supervised questionnaire detailing modifiable risk factors was completed, and advice on lifestyle modification was given. Management of risk factors was generally poor, and was worse in women. Approximately 20% of subjects remained hypertensive, with half of these receiving antihypertensive medication. Examining the primary care records, serum cholesterol was documented in 17.5% of men and 26.5% of women. Of the 722 subjects who had cholesterol measured, 30% of men and 25% of women had cholesterol <5.2 mmol/l. Mean cholesterol was significantly higher in the women (6.1 mmol/l vs. 5.6 mmol/l, p == 0.001). Lifestyle risk management was also poor, with significant numbers smoking and drinking more than recommended. Women were more overweight than men (mean BMI 27.9 kg/m(2) vs. 26.9 kg/m(2), p==0.006). Aspirin was being taken by 56% of patients.
引用
收藏
页码:245 / 250
页数:6
相关论文
共 23 条
[1]
COLLABORATIVE OVERVIEW OF RANDOMIZED TRIALS OF ANTIPLATELET THERAPY .1. PREVENTION OF DEATH, MYOCARDIAL-INFARCTION, AND STROKE BY PROLONGED ANTIPLATELET THERAPY IN VARIOUS CATEGORIES OF PATIENTS [J].
ALTMAN, R ;
CARRERAS, L ;
DIAZ, R ;
FIGUEROA, E ;
PAOLASSO, E ;
PARODI, JC ;
CADE, JF ;
DONNAN, G ;
EADIE, MJ ;
GAVAGHAN, TP ;
OSULLIVAN, EF ;
PARKIN, D ;
RENNY, JTG ;
SILAGY, C ;
VINAZZER, H ;
ZEKERT, F ;
ADRIAENSEN, H ;
BERTRANDHARDY, JM ;
BRAN, M ;
DAVID, JL ;
DRICOT, J ;
LAVENNEPARDONGE, E ;
LIMET, R ;
LOWENTHAL, A ;
MORIAU, M ;
SCHAPIRA, S ;
SMETS, P ;
SYMOENS, J ;
VERHAEGHE, R ;
VERSTRAETE, M ;
ATALLAH, A ;
BARNETT, H ;
BATISTA, R ;
BLAKELY, J ;
CAIRNS, JA ;
COTE, R ;
CROUCH, J ;
EVANS, G ;
FINDLAY, JM ;
GENT, M ;
LANGLOIS, Y ;
LECLERC, J ;
NORRIS, J ;
PINEO, GF ;
POWERS, PJ ;
ROBERTS, R ;
SCHWARTZ, L ;
SICURELLA, J ;
TAYLOR, W ;
THEROUX, P .
BMJ-BRITISH MEDICAL JOURNAL, 1994, 308 (6921) :81-100
[2]
[Anonymous], 1996, N Z Med J, V109, P224
[3]
MANAGEMENT OF HYPERLIPEMIA - GUIDELINES OF THE BRITISH-HYPERLIPEMIA-ASSOCIATION [J].
BETTERIDGE, DJ ;
DODSON, PM ;
DURRINGTON, PN ;
HUGHES, EA ;
LAKER, MF ;
NICHOLLS, DP ;
REES, JAE ;
SEYMOUR, CA ;
THOMPSON, GR ;
WINDER, AF ;
WINOCOUR, PH ;
WRAY, R .
POSTGRADUATE MEDICAL JOURNAL, 1993, 69 (811) :359-369
[4]
A British cardiac society survey of the potential for the secondary prevention of coronary disease: ASPIRE (Action on Secondary Prevention through Intervention to Reduce Events) - Principal results [J].
Bowker, TJ ;
Clayton, TC ;
Ingham, J ;
McLennan, NR ;
Hobson, HL ;
Pyke, SDM ;
Schofield, B ;
Wood, DA .
HEART, 1996, 75 (04) :334-342
[5]
[6]
BURR ML, 1989, LANCET, V2, P757
[7]
Secondary prevention in coronary heart disease: baseline survey of provision in general practice [J].
Campbell, NC ;
Thain, J ;
Deans, HG ;
Ritchie, LD ;
Rawles, JM .
BMJ-BRITISH MEDICAL JOURNAL, 1998, 316 (7142) :1430-1434
[8]
Secondary prevention clinics for coronary heart disease: randomised trial of effect on health [J].
Campbell, NC ;
Thain, J ;
Deans, HG ;
Ritchie, LD ;
Rawles, JM ;
Squair, JL .
BMJ-BRITISH MEDICAL JOURNAL, 1998, 316 (7142) :1434-1437
[9]
COULTER A, 1994, BRIT MED J, V308, P308
[10]
RANDOMIZED CONTROLLED TRIAL OF HEALTH PROMOTION IN GENERAL-PRACTICE FOR PATIENTS AT HIGH CARDIOVASCULAR RISK [J].
CUPPLES, ME ;
MCKNIGHT, A .
BRITISH MEDICAL JOURNAL, 1994, 309 (6960) :993-996